+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Marketing Authorization"

From
From
Variations to Marketing Authorisations (November 11-12, 2026) - Product Thumbnail Image

Variations to Marketing Authorisations (November 11-12, 2026)

  • Training
  • November 2026
  • 2 Days
  • Global
The Common Technical Document (October 21-22, 2026) - Product Thumbnail Image

The Common Technical Document (October 21-22, 2026)

  • Training
  • October 2026
  • 2 Days
  • Global
Pharmaceutical Development of ATMPs (September 28-29, 2026) - Product Thumbnail Image

Pharmaceutical Development of ATMPs (September 28-29, 2026)

  • Training
  • September 2026
  • 2 Days
  • Global
The FDA Drug Approval Process (September 24-25, 2026) - Product Thumbnail Image

The FDA Drug Approval Process (September 24-25, 2026)

  • Training
  • September 2026
  • 2 Days
  • Global
Variations to Marketing Authorisations (June 2-3, 2026) - Product Thumbnail Image

Variations to Marketing Authorisations (June 2-3, 2026)

  • Training
  • June 2026
  • 2 Days
  • Global
The Common Technical Document (May 14-15, 2026) - Product Thumbnail Image

The Common Technical Document (May 14-15, 2026)

  • Training
  • May 2026
  • 2 Days
  • Global
EU Pharmaceutical Regulations and Strategy (October 5-6, 2026) - Product Thumbnail Image

EU Pharmaceutical Regulations and Strategy (October 5-6, 2026)

  • Training
  • October 2026
  • 2 Days
  • Europe
Orphan Drug Growth Opportunities - Product Thumbnail Image

Orphan Drug Growth Opportunities

  • Report
  • March 2024
  • 78 Pages
  • Global
From
From
From
From
Loading Indicator

The Marketing Authorization market is a key component of the Drug Discovery process. It is the process of obtaining approval from regulatory authorities to market a drug or medical device. This process involves submitting a dossier of data to the relevant regulatory body, which is then reviewed to ensure the product meets safety and efficacy standards. The dossier includes pre-clinical and clinical data, manufacturing information, and other relevant information. The process also includes post-marketing surveillance to ensure the product continues to meet safety and efficacy standards. Companies in the Marketing Authorization market include AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more